4DMedical Raises $100 Million to Expand Lung Imaging Platform Across U.S. Hospitals – Monday, February 9, 2026

4DMedical has secured $100 million in funding to expand its lung imaging SaaS platform across the United States. This strategic investment aims to enhance lung diagnostics and treatment monitoring through advanced imaging technology.

Who should care: hospital CIOs, clinical operations leaders, healthcare IT directors, compliance officers, and medical technology decision-makers.

What happened?

4DMedical, a pioneer in medical imaging technology, has raised $100 million to accelerate the rollout of its cutting-edge lung imaging software-as-a-service (SaaS) platform within the United States. This substantial funding round reflects the increasing demand for sophisticated diagnostic tools in respiratory healthcare, driven by the need for more precise and timely lung disease detection. The company’s platform utilizes advanced imaging techniques to deliver detailed, dynamic insights into lung function, which are critical for enhancing the accuracy and efficiency of diagnosing and monitoring conditions such as chronic obstructive pulmonary disease (COPD) and asthma. By providing clinicians with a more comprehensive and functional view of lung health, 4DMedical’s technology supports earlier detection and enables more personalized treatment strategies tailored to individual patient needs. The planned U.S. expansion represents a major growth opportunity, allowing 4DMedical to integrate its platform across a wider array of healthcare settings—from hospitals to outpatient clinics—thereby improving patient outcomes and operational efficiencies on a national scale.

Why now?

This expansion comes at a crucial moment as the healthcare sector increasingly prioritizes precision medicine and personalized care approaches. Over the past 18 months, there has been a marked shift toward adopting advanced imaging technologies to better manage chronic respiratory diseases, driven by rising prevalence and the urgent need for more effective treatment pathways. Simultaneously, the U.S. healthcare system’s accelerating digital transformation and emphasis on data-driven clinical decision-making create an ideal environment for 4DMedical’s platform adoption. The recent funding equips the company to seize these converging trends, meeting the growing demand for innovative, technology-enabled diagnostic solutions that can improve patient care and reduce costs.

So what?

Strategically, this funding and expansion position 4DMedical as a leading innovator in the U.S. lung imaging and diagnostics market, with the potential to establish new clinical standards. For healthcare providers, the platform promises enhanced diagnostic precision and workflow efficiency, which can translate into better patient outcomes and lower overall healthcare expenditures. Additionally, integrating 4DMedical’s SaaS into clinical environments can streamline respiratory diagnostics, improve data analytics capabilities, and support more informed, timely clinical decisions. This advancement not only benefits patient care but also aligns with broader healthcare goals of operational excellence and value-based care.

What this means for you:

• For hospital CIOs: Evaluate how integrating 4DMedical’s platform can elevate diagnostic accuracy and improve patient care outcomes within your institution.
• For clinical operations leaders: Consider adopting the platform to optimize respiratory diagnostics and tailor treatment plans more effectively.
• For healthcare IT directors: Assess the technical requirements and ensure interoperability of 4DMedical’s SaaS with existing hospital information systems.

Quick Hits

• Impact / Risk: Expanding 4DMedical’s platform could significantly enhance lung disease diagnostics but requires careful integration to prevent workflow disruptions.
• Operational Implication: Hospitals may need to upgrade IT infrastructure to support the platform, ensuring seamless data exchange and system compatibility.
• Action This Week: Review current respiratory diagnostic workflows; schedule discussions with 4DMedical representatives to explore collaboration; evaluate IT readiness for platform deployment.